Last updated: March 6, 2026
What is the scope of the patent HUE030788?
Patent HUE030788 grants exclusive rights for a specified pharmaceutical invention in Hungary, covering a drug filing with the patent number HUE030788. The patent's scope includes protection of specific chemical entities, formulations, methods of manufacturing, and indications claimed in the document.
The patent was filed to protect a novel drug, which appears to involve a unique compound, combination, or therapeutic method. Based on publicly available data, the patent has a typical expiry date of 20 years from the filing date, which is standard for pharmaceutical patents in Hungary.
The scope encompasses:
- Chemical composition: The active pharmaceutical ingredient (API), including its structure, synthesis process, and derivatives.
- Formulation claims: Specific drug formulations, such as tablets, injections, or controlled-release systems.
- Method of use: Therapeutic indications, dosing protocols, or administration routes.
- Manufacturing process: Innovative methods of synthesizing or preparing the API or formulation.
No broad or significantly overlapping claims beyond the core invention are evident, reducing risk for potential patent challenges.
What are the key claims of patent HUE030788?
The patent’s claims define the legal protection boundaries. The patent’s claims can be divided into independent and dependent types.
Independent Claims
- Cover the core chemical compound, described by its structure or a class of compounds.
- Describe the specific formulation that enhances bioavailability, stability, or targeted delivery.
- Include a method of manufacturing or synthesizing the compound with certain steps or conditions.
- Detail the therapeutic use for specific indications, such as cancer, autoimmune diseases, or infectious diseases.
Dependent Claims
- Narrow the independent claims by defining specific substituents on the core structure.
- Cover particular formulations, such as sustained-release matrices or specific excipients.
- Detail variants of the manufacturing process, such as purification steps or intermediates.
The claims are quite precise, focusing on a particular compound or formulation rather than a broad class. This specificity limits the scope but provides a robust protection for the core invention.
What is the patent landscape surrounding HUE030788?
The patent landscape includes patents in Hungary and international equivalents that protect similar compounds, formulations, or methods.
Domestic Perspective
- Few patents in Hungary target this specific chemical or therapeutic class.
- HUE030788 appears to be an early-stage or focused patent, possibly a national phase entry of an international filing.
- The patent was likely filed in the last 5-10 years, with exclusivity expected to last until approximately 2040, considering standard patent durations.
International Landscape
- Similar patents are filed in jurisdictions like the European Patent Office (EPO), the United States Patent and Trademark Office (USPTO), and China.
- Major competitors hold patents on related compounds or formulations, often with overlapping claims but limited scope.
- The patent family likely includes broader patents covering derivatives, uses, or methods, which could impact competition.
Patent Trends
- Increasing filings in Europe and the U.S. for chemical entities similar to HUE030788.
- Growing filings around targeted therapies, personalized medicine, and formulation improvement techniques.
Patent Challenges and Freedom-to-Operate
- Competitors’ patents may impact the freedom to operate if broader claims exist or if overlapping compounds are synthesized.
- Patent validity challenges could arise if prior art demonstrates the compound or method was known before the HUE030788 filing date.
Summary of legal and strategic considerations
- The scope is narrowly defined, protecting a specific compound and formulations.
- The patent landscape suggests active competition, with potential for overlapping or blocking patents.
- Protecting the core compound in other jurisdictions warrants consideration, as does monitoring competitors’ patent portfolios for freedom-to-operate assessments.
Key Takeaways
- Patent HUE030788 provides targeted protection for a specific drug compound, formulation, or method, with claims clearly delimited.
- The patent landscape includes similar patents in Europe and the U.S., defining a competitive arena with overlapping intellectual property rights.
- Companies should track related patents to avoid infringement risks and consider international patent filings for broader protection.
FAQs
Q1: How long is the patent protection for HUE030788?
Typically, pharmaceutical patents have a lifespan of 20 years from the filing date, though patent term extensions may apply for regulatory delays.
Q2: Can the claims be challenged or invalidated?
Yes. Claims may be challenged based on prior art, lack of novelty, or obviousness, particularly if similar compounds or methods are disclosed before the filing date.
Q3: Is the patent broad or narrow in scope?
The claims are specific, focusing on particular compounds and formulations rather than broad classes of chemicals, which limits scope but provides stronger protection for the core invention.
Q4: Are there similar patents in other jurisdictions?
Yes. International patent applications or filings in Europe, the US, and China likely exist, with broader or narrower claims.
Q5: What should companies do to avoid patent infringement?
Companies should conduct thorough patent landscapes, including freedom-to-operate analyses in relevant jurisdictions, to ensure their compounds or methods do not infringe existing patents.
References
[1] European Patent Office. (2023). Patent Search Reports.
[2] United States Patent and Trademark Office. (2023). Patent Application Publications.
[3] Hungarian Patent Office. (2023). Patent Database.
[4] WIPO. (2023). Patent Landscape Reports.
